The past week has been tough on the stocks of major medtech companies, which, like many, are figuring out how to manage the global trade war.

Cala today announced new results from multiple clinical studies further expanding the body of evidence for its TAPS therapy.

Hologic (Nasdaq: HOLX) announced that it appointed Wayde McMillan to its board of directors, effective April 4, 2025.

ICU Medical (Nasdaq: ICUI) today announced new regulatory milestones that open up a new category for its infusion systems.

Johnson & Johnson MedTech‘s  Medical announced today that it initiated a study evaluating its Javelin coronary IVL catheter.

Boston Scientific (NYSE: BSX) announced on social media that it completed its previously announced acquisition of Bolt ...

NeuroOne (Nasdaq:NMTC) announced today that it priced an underwritten registered public offering of common stock worth $8 million.

"The ongoing gutting of the FDA is likely to cause American deaths," said the CEO of one medical device developer.

Anaconda Biomed announced the enrollment and treatment of the first U.S. patient in a clinical trial of its ANA Funnel ...

Owens & Minor (NYSE:OMI) announced that it upsized and priced an offering of $1 billion in senior secured notes due 2030.

D-printed implant maker Restor3d announced today that it completed a funding round, bringing in proceeds totaling $38 million ...